The definition of a Part D rebatable drug includes drugs approved under a new drug application under section 505(c) of the Federal Food, Drug, and Cosmetic (FD&C) Act (that is, brand name drugs), generic drugs approved under section 505(j) of the FD&C Act that meet certain statutory criteria (that is, sole source generic drugs), and biologicals licensed under section 351 of the Public Health Service Act (PHS), including biosimilars
1 2 3 Negcio da Costa da Mina e comrcio atlntico: tabaco, acar, ouro e trfico de escravos, Pernambuco (1654-1760) (Doutorado em Histria Econmica thesis) (in Portuguese)
Sometimes, I think I notice a touch of Cyprian Latakia, but I believe the Orientals cause that
We are interested in approaches that would encourage multispecialty groups to report more than one MVP